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Regina Célia PASCHOAL(1), Mário Hiroyuki HIRATA(1), Rosário Crespo HIRATA(1), Márcia de Souza Carvalho MELHEM(2),
Amanda Latercia Tranches DIAS(3) & Claudete Rodrigues PAULA(3)
SUMMARY
Cryptococcus neoformans detection was optimized using PCR technique with the objective of application in the clinical laboratory
diagnosis. The amplification area was ITS and 5,6S which encodes the ribosomal RNA (rRNA). A total of 72 cerebrospinal fluid
(CSF) samples were used, obtained from cases with and without AIDS. The patients had cryptococcal meningitis (n = 56) and
meningitis caused by other agents (n = 16). The results demonstrated that PCR test had the highest sensitivity rates, superior to culture
(85.7%) and to India ink test (76.8%). PCR was found to be sensitive in detecting 1 cell/mL and highly specific since it did not
amplify other fungal DNA. The comparative analysis of the methods showed that PCR is more sensitive and specific and is applicable
as an important laboratorial resource for neurocryptococcosis diagnosis.
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INTRODUCTION
Cryptococcosis is a cosmopolitan infection caused by Cryptococcus
neoformans, an encapsulated yeast pathogenic to humans and
animals1,13,18.
In the last decades, cryptococcosis has been assuming a prominent
role at public health level due to the growing number of AIDS individual
cases2,3,20. It is an important opportunist systemic mycosis that involves
mainly immunosuppressed individuals and starts when C. neoformans
penetrates the organism, lodging primarily in the lungs and later presents
a notable tropism for the central nervous system7,9,14. Molecular tests for
detecting nucleic acids of infectious agents in biological samples have
been developed for C. neoformans. These can be done in various clinical
materials, such as blood, liquor, secretions, cutaneous scrapings,
bronchial alveolar aspirate and urine24. For the diagnosis of
neurocryptococcosis the application of more sensitive and specific
laboratorial techniques are necessary in order to introduce early and
specific antifungal therapy. PCR offers a good alternative11. It constitutes
a method of choice for early alternative diagnosis to the conventional
ones and contributes to supply important subsidies to the diagnosis of
this pathology mainly when there is clinical suspicion of the disease12.
The DNA of C. neoformans can be detected by initiators that encode the
ribosomal RNA (rRNA) gene 16S-5S,8S-23S which is highly
conserved4,17.
In this work the single-step PCR technique on clinical samples was
optimized by utilizing the initiator pairs CN-4/CN-5 that are specific for
C. neoformans and do not amplify the DNA of other yeast17. This
technology involves yeast acid nucleic isolation, amplification by PCR
and identification by electrophoresis on polyacrylamide gel with silver
salt staining.
MATERIALS AND METHODS
1. Biological samples: The CSF samples were obtained from
individuals with and without neurocryptococcosis signals. The collection
was carried out through lumbar and occipital puncture. The material
was dripped directly into sterile tubes and divided into three groups for
later analysis:
Group 1: Constituted of 43 individuals with or without clinical
suspicion of meningitis and laboratorial diagnosis of meningitis,
independent of age, color or sex with positive culture for C. neoformans.
Group 2: Constituted of 13 individuals with clinical picture and
laboratorial diagnosis of meningitis, independent of age, color or sex,
with negative culture and positive China ink test for C. neoformans.
Group 3: Constituted of 16 individuals with or without clinical
suspicion of meningitis caused by other agents not related to C.
neoformans, independent of age, color or sex, with negative culture and
India Ink Test for C. neoformans.
Other methodologies were evaluated for DNA extraction from C.
neoformans in culture and in CSF samples: from simple extraction with
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glass spheres10,19,28, extraction of DNA with sodium iodide15 and with
guanidine thiocyanate24 to more complex methods involving
enzymes22,25,26,27,29.
2. DNA extraction: The SANDHU extraction technique24 was
performed: 2 mL of clinical sample were placed in a sterile 15 mL
polypropylene test tube and centrifuged at 5000 rpm during five min.
The sediment was transferred to another sterile 1.5 mL microtube. Then
500 µL of the reagent GPT (6M guanidine thiocyanate) dissolved in
50 mM TRIS (pH 8.3) was added after mixing with an equal volume of
phenol TRIS (pH 8.0). The resulting mixture was thoroughly stirred and
immediately incubated by boiling water bath during 15 min. Next, 250 µL
of chloroform: amyl alcohol (24:1 per volume) was added under vigorous
stirring followed by centrifugation for five min at 12000 rpm. The
aqueous phase was transferred to a new and sterile tube followed by
addition of one mL 100% isopropanol. This set was freezer-stored for a
minimum of one h and then centrifuged for 10 min at 12000 rpm. The
supernatant was discharged. Next, 500 µL 70% ethanol was added to
the sediment. Centrifugation during five min at 12000 rpm was performed
and the sediment was resuspended in 50 µL buffer TE (10 mM TRIS, 1
mM EDTA, pH 8.0) and freezer-stored at -20 °C until use.
3. Primers: For the C. neoformans genome amplification we selected
and tested primers “sense” CN-5 (3’GAA GGG CAT GCC TGT TTG
AGA G 5’) and “antisense” CN-4 ( 5’ATC ACC TTC CCA CTA ACA
CAT T 3’) as described by MITCHELL et al.16 which are specific for C.
neoformans.
4. PCR method: After the extraction, 5 µL DNA of each sample were
added to the 200 µL Eppendorf type tubes. Next, buffer solution for PCR
was pipetted [75 mM TRIS-HCl (pH 9.0), 50 mM KCl, 2 mM MgCl2,
BIOTOOLS - B&M Labs, S.A]; 200 mM of each dNTP (dATP, dTTP,
dGTP and dCTP, Pharmacia Biotech), 1.5 U/µL Taq DNA polymerase
(BIOTOOLS - B&M Labs, S.A.); 10 ρmol/µl of each primer (Gibco-BRL
Life Technologies NY-USES) for a reaction final volume of 50 µL. The
amplification was realized in thermocycle GeneAmp 2400 (Perkin-Elmer,
USA) and consisted of one cycle at 95 oC for 7 min (hot start), 40 cycles at
95 oC for 45 sec (denaturation), 60 oC for one min. (annealing), 72 oC for
1.5 min (extension) and 72 oC for 7 min (final extension).
4.1. Analysis of the PCR products: The electrophoresis separation
was accomplished on 8% polyacrylamide gel with 20 µL of the PCR
product containing 10 µL of run buffer (6X concentrated). The system
was submitted to 95 Volts during 6 h and later silver-stained through
impregnation technique to permit observation of the DNA dark brown
color bands (Fig. 1)
4.2. Specificity of the primers: The chosen primers CN-4 and CN-
5 presented high specificity for C. neoformans serotypes A, B, C and D
cultures for CSF samples where the yeast was present. The primer did
not amplify other types of yeasts such as: Candida albicans ATCC 64548,
Candida parapsilosis ATCC 22019, Candida tropicalis ATCC 750,
Candida glabrata ATCC 90030, Cryptococcus luteolus ICB,
Cryptococcus terreus ICB, Cryptococcus diffluens ICB 72 and
Rhodotorula glutinis ICB 32 (Fig. 2).
4.3. Sensitivity of the PCR method: The technique was sensitive
for the detection of up to 1 cell/ mL in CSF samples. The PCR
amplification yielded a DNA fragment of 136 bp in all concentrations
(Fig. 3). Each reaction was accompanied with control reagents and
positive control with 6,000 cells/mL (data not showed).
RESULTS
In Table 1, the results obtained by culture, India Ink Test and PCR
techniques were compared in the study of 72 CRL samples (groups 1, 2
and 3). It was found that all the techniques were 100% specific (75.9 -
100%) and that PCR technique amplifies only C. neoformans specie
DNA11,16.
Fig. 2 - PCR Sensitivity. Line 1: reagent control; line 2: positive control; line 3,4,5 and 6: C.
neoformans serotype A, B, C and D; line 7: DNA ladder 123 bp; lines 8, 9 and 10 Cryptococcus
terreus, Cryptococcus diffluens and Cryptococcus luteolus; line 11: Rhodotorula glutinis,
lines 12, 13 and 14: Candida albicans, Candida tropicalis and Candida glabrata.
Fig. 1 - Electrophoretic separation on 8% polyacrylamide gel of the PCR products from C.
neoformans in CSF sample extracted with guanidine thiocyanate. Line 1 reagent control; line
5 positive control; lines 2, 3, 4, 6-8, 10-20 samples of CSF; line 9: DNA ladder 100bp
(standard);
Fig. 3 - Electrophoresis on 8% polyacrylamide gel from clinical sample PCR product with
different amounts of cells. Lines 1: 2 cells; 2: 11 cells; 3: positive control; 4: 70 cells; P:
100bp molecular weight DNA pattern; 5: 40 cells; 6: zero cell; 7: 1 cell; 8: zero cell; 9: 58
cells; 10: 1 cell; 11: 14 cells; 12: 65 cells; 13: 28 cells; 14: 110 cells.
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The PCR method presented the greatest sensitivity with 92.9% (81.9
- 97.7%). The specificity was 100% (75.9 - 100%), with positive predictive
value 100% (91.4 - 100%), there were no false positives; negative predictive
value was 80.0% (55.7 - 93.4%) with 20% false negatives which refer to
four samples of group 2 that presented positive India Ink Test. The India
Ink Test sensitivity 85.7% (73.2 – 93.2), specificity 100% (75.9 - 100%),
positive predictive value 100% (90.8 - 100%) and negative predictive value
66.7% (44.7 - 83.6%) generating a false negative of 33.3%, due to 8 samples
of group one that presented positive culture but negative values with India
Ink test. Nevertheless, the culture that was considered the gold standard of
this study presented sensitivity 76.8% (63.3 - 86.6%), specificity 100%
(75.9 - 100%), positive predictive value 100% (89.9 - 100%) and negative
predictive value 55.2% (36.0 - 73.0%), generating false negatives of 44.8%
due to 13 samples of group 2 that presented positive value with India ink
test but negative culture.
DISCUSSION
In the present study, we optimized the method for the detection of
C. neoformans by PCR technique in CSF samples with the objective of
developing a new diagnosis resource that, associated with methods
already used in laboratorial routine, can increase the diagnostic efficiency
in cases where conventional techniques are inadequate11.
At the standardization phase of DNA extraction method, the
extraction efficiency, speed, simplicity of manipulation, ease of obtaining
the material and low cost were taken into account; since these
requirements are indispensable in order to ensure the method is applicable
for routine laboratorial use. From simple DNA extraction with glass
beads10,19,28, DNA extraction with sodium iodine methods16 and with
guanidine thiocyanate24 to more complex methods involving
enzymes21,22,25,26,27,29,30 all them were efficient for the extraction of DNA
from cultures of C. neoformans. The extraction with guanidine
thiocyanate is fast, presents easy execution, low cost and is much more
efficient for CSF sample extraction than C. neoformans culture. This
was demonstrated to be the only efficient technique for C. neoformans
DNA extraction from clinical samples, working even with small amounts
of yeast.
In order to evaluate the specificity of the primers, DNA of several
ATCC and ICB yeast strains were tested and none of their DNA was
amplified. Strains for the four serotypes of C. neoformans were also
utilized as a standard. The validity of the methodology was studied
through the evaluation of efficiency in the case of material obtained at
the medical clinic. For that, CSF materials were studied as samples and
were subdivided into three study groups:
Group 1, constituted of individuals with clinical diagnosis of
neurocryptococcosis, with positive results for culture and India Ink test,
PCR demonstrated high sensitivity (100%) and specificity (100%) without
any false negatives; Group 2, constituted of neurocryptococcosis cases,
with positive value to India Ink test and negative culture, PCR proved to
be sensitive (69.2%) and specific (100%). In four individuals (30.8%)
that presented negative PCR, two of the corresponding sample cells were
not found; in the other two there were three and 46 cells, respectively.
This was probably due to the capsule being thicker in clinical samples
compared to those of cultures. Thus, the high thickness of the capsules
may have considerably hindered the cellular lysis. Another hypothesis for
this finding could be interferents in CSF, which may have inhibited the
PCR. It is supposed that these interferents may be related to the great
amount of antibiotics, anti-retroviral agents, proteases and other drugs
administered to the AIDS patient, which may not have been eliminated at
the DNA extraction. Occasionally, the presence of great capsular
polysaccharide amounts can alter the activity of Taq polymerase and
compromise the accuracy of PCR5. In group 3, constituted of individuals
with other neurological diseases not related to C. neoformans, PCR was
demonstrated to be specific (100%) and did not present fragment
amplification in any of the samples and there were no false positive results.
Comparison of the three groups showed a predominance of 58 male
individuals (80.6%) with a mean age between 36 to 39 years and a less
expressive number of 14 female individuals (19.4%) with a mean age
from 23 to 36 years.
PCR presented a higher sensitivity in relation to India ink test and
culture due to the following factors that interfere in the C. neoformans
growth and visualization: a) for the India ink test be positive it is necessary
that there are more than 103 CFU/mL; b) C. neoformans shows different
forms and sizes in CSF and sometimes does not present capsules,
impeding its visualization; c) the culture medium composition has to
offer some source of iron; d) some aberrant strains of C. neoformans are
unable to grow in BHI (brain and heart infusion) medium, but grow well
Table 1
Comparison of results obtained by PCR method, culture and India ink test in 72 CSF samples from individuals with or without clinical diagnosis of cryptococcal meningitis
Samples Cryptococcal Other Sensitivity Specificity PPV NPV FP FN
n = 72 meningitis meningites (%) (%) (%) (%) (%) (%)
n = 56 n = 16
Culture Pos 43 0 76.8 100 100 55.2 0 0
Neg 13 16 (63.3-86.6) (75.9-100) (89.8-100) (36.0-73.0)
China Ink Test Pos 48 0 85.7 100 100 66.7 0 33.3
Neg 8 16 (73.2-93.2) (75.9-100) (90.8-100) (44.7-83.6)
PCR Pos 52 0 92.9 100 100 80.0
Neg 4 16 (81.9-97.7) (75.9-100) (91.4-100) (55.7-93.4)  0  20.0
Pos = positive; Neg = negative; PPV = positive predictive value; NPV = negative predictive value; FP = false positive; FN = false negative
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on SDA (Sabouraud’s dextrose agar); e) the growth can be significantly
inhibited at temperatures between 39 - 40 ºC; f) some patients that
received antifungal therapy can present negative culture, but positive
result to India ink test at the end of therapy, irrespective of clinical
improvement; and g) pH above 7.6 causes the death of the yeast5.
India ink test presented 85.7% (73.2 - 93.2%) sensitivity; positive
predictive value of 100% (90.8 - 100%) and did not present false
negatives, but a negative predictive value of 66.7% (44.7 - 83.6%) in
that 33.3% false negatives were found, amounting to eight samples from
group one that were negative and under direct microscopy presented an
absence of cells that probably harmed the color exam.
In relation to culture evaluation, a sensitivity of 76.8% (63.3 - 86.6%)
was found due to 13 negative samples from group two. Of these, five
samples were negative under direct microscopy, five samples presented
low cellularity (3, 3, 28, 30 and 46 cells) and three high cellularity (110,
148 and 1080 cells). This can occur when antifungal therapy has already
been initiated, thereby inhibiting cellular growth and negativation of the
culture, but the presence of the yeast is detected by the India ink test and
therefore in some cases is positive until the end of the therapy, irrespective
of clinical improvement. It has yet to be clarified why these nonviable
yeasts occasionally persist for months after the antifungal therapy5.
RAPPELLI et al.23 utilized the same protocol of DNA extraction of
SANDHU et al.24 and realized the identification of C. neoformans by
“nested” PCR technique and observation of the DNA fragments on
agarose gel stained with ethidium bromide. The demonstrated results, in
accordance with SANDHU et al.24 were significantly better for the
following data:
In the protocol of RAPPELLI et al.23 all CSF samples used had at
least one cell per field in India ink test and presented latex agglutination
titer 1:1024, data strongly indicative of neurocryptococcosis .
Some authors detected DNA from samples that did not present culture
and India ink test, positive. These authors used “nested” PCR to increase
the DNA detection sensitivity. This method is both time consuming and
expensive besides the major inconvenience that there is a risk of causing
contamination6,8.
The primer pairs used in the “nested” PCR also amplify the
saprophytic Filobasidiella depauperata and so can give a false positive
result. The primers CN-4 and CN-5 used in this study do not amplify
yeast other than C. neoformans because they are species-specific17.
Hence, the strategy developed in this study allowed a reduction in
the time for C. neoformans detection and identification since it entails
just a single step for the amplification, which avoids contamination and
offers satisfactory results with the same sensitivity as the method proposed
by RAPPELLI et al.23.
The results show that DNA extraction with guanidine thiocyanate
was the only efficient method for C. neoformans DNA extraction in
CSF samples, besides being fast and easy to perform. The PCR method
has proven to be efficient in detecting up to one cell/mL in CRL samples,
even in cases where antifungal therapy has been initiated. In the overall
evaluation of the studied groups, this technique showed sensitivity of
92.9% and specificity of 100%. It can be used for the diagnosis of
neurocryptococcosis, therefore its use is viable in the laboratorial routine.
The PCR method is sensitive, specific, and reproducible and
represents a promising method for analysis of CSF samples from patients
with clinical suspicion of neurocryptococcosis.
RESUMO
Neurocriptococose: diagnóstico por PCR
A detecção de Cryptococcus neoformans em líquor foi otimizada pela
técnica de PCR. A amplificação foi realizada nas áreas ITS e 5,6S do
RNA ribossomal (rRNA). Foram estudados 72 líquors obtidos de casos
de pacientes com e sem AIDS. Os pacientes eram portadores de meningite
criptocócica (n = 56) e meningite ocasionada por outros agentes (n = 16).
Os resultados demonstraram que a técnica tem alta sensibilidade, superior
a cultura (85,7%) e ao teste  da tinta da china (76,8%). A técnica de PCR
pode detectar 1 célula/mL de líquor e é altamente específica. A análise
comparativa dos três métodos, tinta da china, cultura e PCR, demonstrou
que o último é muito mais sensível e específico, podendo ser aplicável
como importante recurso laboratorial no diagnóstico da neurocriptococose.
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